Off‐target binding of drugs is not a well‐studied line of inquiry, but there is interesting evidence from the chick form‐deprivation model that supports a role for off‐target, and not muscarinic, receptor effects for myopia treatment with high concentrations of atropine, himbacine, and MT3. The gene discussed is MT3; the disease is myopia.